Table 5. Multivariate analyses of clinicopathologic parameters on recurrence-free and overall survival in patients with adenocarcinoma.
|
Adenocarcinoma (n=222)
|
|||||
|---|---|---|---|---|---|
|
Recurrence-free survivala
|
Overall survivala
|
||||
| Variables | N | OR (95% CI) | P-value | OR (95% CI) | P-value |
| Parametrial involvement | |||||
| No | 200 (90.1) | Reference | Reference | ||
| Yes | 22 (9.9) | 3.46 (1.46–8.19) | 0.005 | 6.17 (2.55–14.95) | 0.002 |
| Lymph node metastasis | |||||
| No | 188 (84.7) | Reference | Reference | ||
| Yes | 34 (15.3) | 2.45 (1.14–5.30) | 0.022 | 2.79 (1.25–6.25) | 0.012 |
Abbreviations: CI=confidence interval; LVSI=lymphovascular space invasion; OR=odds ratio.
a
The analysis included FIGO stage, tumour size, depth of stromal invasion, parametrial involvement, resection margin, LVSI, lymph node metastasis, and adjuvant treatment.